Company Highlights

All
Announcements
Press Releases
In The News

Press Release
Integrated Nanotherapeutics and Breakthrough T1D Collaborate to Advance Development of an Immune Tolerizing Therapeutic to Treat Type 1 Diabetes.

September 9, 2024

Press Release
Integrated Nanotherapeutics is presenting T1D preclinical data at the Federation of Clinical Immunology Societies (FOCIS) 2024 Annual Meeting, June 18 – 21, in San Francisco.

June 11, 2024

Press Release
Integrated Nanotherapeutics Secures Genome Canada GAPP Funding to Advance Multi-Cargo mRNA/LNP Therapy for Type 1 Diabetes Toward the Clinic.

March 18, 2026